Talaromyces marneffei - mycosis

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Mycosis by Talaromyces marneffei; System mycosis; Talaromyces mycosis

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Systemic infectious disease caused by a dimorphic pathogen (formerly Penicillium marneffei), which poses a potentially fatal risk, particularly in HIV-infected persons. The infection is the third most frequent oppertunistic infection in Southeast Asia among HIV-infected persons (after tuberculosis and cryptococcosis). Mycoses caused by Talaromyces marneffei belong to the AIDS-defining diseases.

PathogenThis section has been translated automatically.

Talaromyces marneffei (formerly Penicillium marneffei) is a dimorphic pathogen of a systemic mycosis with infestation of the lung and other organs. The skin is involved in about 75% of cases. The pathogen is endemic in Southeast Asia; here in North Thailand, South China, Hong Kong, Vietnam, Indonesia, Singapore and Myanmar. The only known natural reservoir is bamboo rats. The route of infection is by inhalation aerogenic; a transmission from person to person is not known.

Clinical featuresThis section has been translated automatically.

In case of immunocompetence clinically inapparent course. Pneumonia has occasionally been reported in children without predisposing underlying disease. In immunosuppressed persons (immunosuppressive therapy, HIV infection), the infection of the lungs (fever, shortness of breath, haemoptysis) can lead to dissemination with hepatosplenomegaly, lymphadenopathy, anaemia, weight loss. Skin lesions: In 2/3 of these patients there is skin manifestation with mollusca contagiosa-like papules, erosions and ulcerations. Oral mucous membrane infection with flat papules, erosions and ulcers may also occur.

HistologyThis section has been translated automatically.

Nodular dermatitis with epitheloid cell granulomas. In PAS staining, detection of intracellular yeast-like fungal elements.

DiagnosisThis section has been translated automatically.

Culture: Depending on the clinical symptoms: cultural evidence of the pathogen from the respiratory tract, blood cultures, bone marrow biopsies, skin biopsies, etc.; Talaromyces (Penicillium) marneffei can be cultivated on conventional fungal culture media within a few days.

Serology: Commercial methods for antigen and antibody detection are not available; antibody detection by immunodiffusion or western blot is possible and may be positive even in HIV infection.

TherapyThis section has been translated automatically.

Good response to Amphotericin B (i.v.) Followed by oral maintenance dose with itraconazole or other triazole antifungals. Since these patients are almost exclusively HIV-infected, antiretroviral therapy is mandatory.

Authors

Last updated on: 29.10.2020